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Background: In England, guidance from National Institute for Clinical Excellence (NICE) states women with a family
history of breast cancer presenting to primary care should be reassured or referred.
We reviewed the evidence for interventions that might be applied in primary care and conducted an audit of
whether low risk women are correctly advised and flagged.
Methods: We conducted a literature review to identify modifiable risk factors. We extracted routinely collected data
from the computerised medical record systems of 6 general practices (population approximately 30,000); of the
variables identified in the guidance. We implemented a quality improvement (QI) intervention called audit-based
education (ABE) comparing participant practices with guidelines and each other before and after; we report odds
ratios (OR) of any change in data recording.
Results: The review revealed evidence for advising on: diet, weight control, physical exercise, and alcohol. The
proportion of patients with recordings of family history of: disease, neoplasms, and breast cancer were: 39.3%, 5.1%
and 1.3% respectively. There was no significant change in the recording of family history of disease or cancer; OR
1.02 (95% CI 0.98-1.06); and 1.08 (95% CI 0.99-1.17) respectively. Recording of alcohol consumption and smoking
both increased significantly; OR 1.36 (95% CI 1.30-1.43); and 1.42 (95% CI 1.27-1.60) respectively. Recording lifestyle
advice fell; OR 0.84 (95% CI 0.81-0.88).
Conclusions: The study informs about current data recording and willingness to engage in ABE. Recording of risk
factors improved after the intervention. Further QI is needed to achieve adherence to current guidance.Background
Breast cancer is the most common cancer in women
and accounts for over 30% of new cancers in females, in
the UK (Additional file 1: Box S1) [1-3]. National Institute
for Health and Clinical Excellence (NICE) guidelines
for familial breast cancer highlight the importance of
recording family history as a predictor of risk for breast
cancer. The key elements of the NICE guidelines are that
people with a family history should be given lifestyle
advice about their breast cancer risk including information
about: hormone replacement therapy (HRT) and oral
contraceptives, lifestyle (including diet, alcohol, etc.),
breastfeeding, family size and timing. The guidance also* Correspondence: s.lusignan@surrey.ac.uk
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reproduction in any medium, provided the orsuggests that people with modifiable risk factors should
have these managed in primary care. The level of risk
depends on: the number of affected relatives, closeness
of relationships and the age at which the relatives
developed breast cancer; the guidelines recommend the
use of information from family history which should be
taken into account in assessing risk and in deciding
whether and when to refer, and when to reassure [4].
Primary care has a role in prevention, promoting in-
creased awareness, detecting presentation early as well as
referral of suspected cancers. Reduction in risk through
prevention is a core function of primary care. Additionally,
early detection and management of cancers is important
and clearly, recording of family history may help clinicians
consider a diagnosis of cancer, stratify risk and make an
appropriate decision about referral. The UK Cancer
Reform Strategy [5] supports early diagnosis. The Royal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of Cancer Diagnosis reported that 87% of cases presented
with symptoms within primary care [6].
Many women consult their general practitioners (GP)
each year with concern over breast cancer risk. 40–50
people with a positive family history of breast, ovarian
or bowel cancer are found on a GPs list of 2000 patients
[7]. Women with increased risk based on a positive family
history as described within NICE guidelines may be ad-
vised to undergo a range of different forms of surveillance,
genetic testing or even preventive management [8]. How-
ever, many can be reassured that their risk is not increased
above that of the general population. These consultations
also provide an opportunity to record non-modifiable risk
of the woman and to give risk-reducing advice such as
modification of lifestyle and environmental factors.
Audit, seeks to improve patient care and outcomes
through a systematic review of care against explicit criteria
and is an established method of promoting quality im-
provement in the care of patients. The Royal College of
Physicians report “Teams without Walls” calls for greater
use of audit as a means of continuous improvement [9].
English primary care lends itself to conducting clinical
audit [10]. There is a registration based system where indi-
viduals can only register with one practice, and that prac-
tice acts as a gatekeeper to secondary care. Everyone has a
national unique identifier, an NHS number, which helps
identify their records. Primary care is universally com-
puterised, nearly all clinicians complete computer records
at the time of the consultation. Many practices have
computerised since the 1990s; with data quality improving
considerably after pay-for-performance based on compu-
terised records was introduced in 2004 [11,12].
We carried out this study to determine whether an
audit-based education improved risk factor manage-
ment in women who have a low risk of breast cancer;
using improved recording of family history and its risk
factors in primary care computerised medical record
systems as our audit criteria. The focus on the audit
was to record family history and record risk factors
where there was evidence that intervention in primary
care affects outcome.
Methods
Overview
This is a before and after study of audit-based educa-
tion (ABE), a non-judgemental quality improvement
intervention to explore concordance with guidance in the
management of people with a family history of breast
cancer in primary care. The study consisted of two phases:
(1) A literature review to identify the lifestyle factors that
may reduce the risk of breast cancer, which might form
part of a quality improvement (QI) initiative in this do-
main. The objective of the literature review was to informwhat elements of the NICE guidance might be amenable
to interventions carried out in primary care; (2) Piloting
the audit-based education process developed in the first
phase in six volunteer practices.
Literature review to explore the association of lifestyle
factors with breast cancer
The literature review was conducted to identify the risk
factors associated with breast cancer. A comprehensive
search of numerous databases was carried out. The sear-
ches were limited to human subjects, English language
and studies from the last ten years. The searches iden-
tified 1119 articles including 312 reviews. The initial
search identified articles prior to 1/1/2010, and was used
to inform the components of the audit based education
programme. It has subsequently been reviewed to include
major literature published since the start of the study.
Inclusion criteria;
 Data representative of the general population.
 Articles which discuss modifiable risk factors at
population level risk.
 Articles only related to breast cancer and not breast
cancer-associated problems (e.g. lymphedema in
breast cancer patients).
 Studies of risk assessments with confidence intervals
or at least P values.
Exclusion criteria:
 Small sample size (n) less than 50.
 Articles in relation to other issues such as familial risk
factors and diagnostic tests (e.g. mammography).
The outputs of the searches were sorted based on title
and abstract into those to be definitely excluded and
those to retain. Findings from about 66 full texts which
included systematic reviews and primary articles were
used for the literature review. (A full copy of the litera-
ture review is available online at: www.clininf.eu/fhbc).
Audit process
We developed an audit based education (ABE) interven-
tion to support this process (Additional file 1: Box S2)
[13]. ABE is a quality improvement (QI) intervention de-
veloped over the last 15 years by SdeL et al., which pro-
vides general practice based education, peer support and
documents the gap between achievement and guidelines.
In observational studies this intervention improved the
quality of cardiovascular disease management [14,15],
and has also been used in a quality improvement trial
[16]; where it has produced a modest but statistically sig-
nificant drop in systolic BP compared with usual practice
[17]. The theoretical basis for this intervention is that
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have small but positive effects on the quality of data re-
cording [18,19]. Any change in data coding that takes
place might be explained by control theory, which sug-
gests that improvements in the quality of data recording
is most likely if feedback is accompanied by a target or
action plan, ideally in writing [20].
In this study, the educational component included
briefing about the importance of breast cancer and its
family history (Additional file 1: Box S1 gives an over-
view). Additionally, we designed data extraction queries
based on the output from the literature review. As family
history and risk factors can be represented by a wide
range of codes we used an established method to ensure
we comprehensively extracted the relevant data. The
variable list extracted is available on-line at: http://www.
clininf.eu/projects/fhbc.
We extracted data from general practice EPR systems
using Morbidity Information Query and Export SynTax
(MIQUEST), a data extraction method sponsored by the
Department of Health of England. We processed these
data using SPSS (Version 18) for statistical analysis [21].
We report the completeness of recording of audit vari-
ables, demographics and key co-morbidities. We planned
to eventually develop self-audit tools for general practice
similar to those we had developed to identify errors in
the coding of diabetes [22,23]. Any inconsistencies be-
tween in coding between baseline and subsequent col-
lection; were corrected by creating a mapping between
sets (Additional file 1: Table S2).
Pilot audit based-education
We collected initial data from six volunteer practices in
South London and fed back these data to representatives
of the pilot practices. The practices developed an action
plan. This involved them deciding how they might raise
general awareness of family history recording, and re-
cording of lifestyle factors by feeding back the presenta-
tions from the baseline meeting, as well as discussing
the workshop outputs at meetings held at general
practices. The key points from the workshop were noted
down and lead GPs who agreed to disseminate through
their usual practice business processes. We then
conducted a second data collection process with these
practices, and then fed this data back to complete the
audit cycle.
The data are reported as two cross-sections at two
time periods, approximately 6 months apart. We used
two cross sections at two different time points so that
the data included recording of lifestyle factors about new
patients who registered during the audit period. We
hypothesised that a practice responding to the interven-
tion might be most likely to ask new patients about any
family history of breast disease.We used Altman’s method to assess any differences
between before and after readings; this method is de-
signed to be used to compare two cross sections mea-
sured at different time points [24]. We have reported
crude and standardised rates of recording. The partici-
pant general practitioners agreed an action plan at the
baseline presentation, which was shared with the rest of
their practice. We report the characteristics, such as
patient demographics, of the practices using descriptive
statistics: mean and standard deviation (SD). We com-
pared comparable data sets using Pearson Chi-square to
report differences in proportion, and we used odds ratios
(OR) and 95% confidence intervals to explore whether
data recording by general practitioners had increased
from pre-to post audit.
A baseline data collection (round 1) was made to in-
vestigate the extent to which NICE guidance was being
followed in terms of the provision of lifestyle advice to
women with a low risk of breast cancer who can be
reassured and managed in general practice. We planned
a data quality workshop (DQW) which is probably the
most important component of the QI process; it is an
interactive process involving representatives of each
practice. The objective of the DQW was twofold: (1) To
share baseline levels of recording between general prac-
tices and their general practitioners; (2) To recognise the
value of recording family history and implementing an
action plan for improved recording and management.
The second data collection (round 2) served to measure
any change in the quality of data recording after six
months. An Example of a DQW presentation is available
online at: www.clininf.eu/fhbc.
Ethical considerations
This intervention meets the National Patient Safety Agency
(NPSA) and National Research Ethics Service (NRES) de-
scriptions of clinical audit [25]. Hence ethics approval was
not sought. There was no attempt to influence the deci-
sions of clinicians and patients.Results
Overview
Although there are many risk factors associated with a
family history of breast cancer; there is a much more
limited number where intervention is known to affect
outcome, which we included in the audit. Whilst re-
cording of the numbers of cases of a family history of
breast cancer did not increase, the odds ratio of re-
cording risk factors where interventions might affect
outcome did. However, practitioners felt they lacked
knowledge of how best to record. Also they felt that
their computer system did not readily support record-
ing of family history.
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associated with breast cancer
The broad consensus from the literature review about
risk factors associated with breast cancer is summarised
below. These formed the “long-list” of potential variables
that might be included in our audit–based education,
quality improvement intervention.
1. Oral contraceptive pills (OCP). There is evidence
of an increase in the risk of breast cancer during use
of OCP with higher dosage being related to higher
risk [26-29]. After cessation of treatment the risk
gradually decreases over time and disappears about
10 years after discontinuation of OCP [26,27].
2. Hormone replacement therapy (HRT). Long term
HRT apparently increases breast cancer risk
especially when used from 50 years of age [30]. The
risk is greatest for combined oestrogen-progestogen
preparations (CHRT)[26,31,32] and lowest for
oestrogen-only preparations of HRT (ERT) [33,34].
This effect is limited when Body Mass Index (BMI)5
is less than 25 kg/m2. According to the
recommendation by the British Menopause Society,
HRT may be given for symptom relief in the short
term (up to 5 years) but long term use needs to be
assessed individually at regular intervals [35].
3. Breastfeeding. Breastfeeding is reported to be
protective for breast cancer [36,37]. Decreased risk
is related to average length of time of breastfeeding
[38,39]. Risk of breast cancer seems to decrease by
approximately 4.3% for every 12 months of
breastfeeding [27].
4. Alcohol. It is reported that there is about a 10%
increased risk of breast cancer for each additional
unit (10–12 g) of alcohol per day [40]. Risk appears
to be 28-50% greater for those who typically
consume approximately two drinks per day
compared to those who do not drink [41-44].
Consumption of one drink per day or less does not
significantly affect risk of breast cancer [45-47].
There is no difference in risk based on type of
alcohol consumed [48].
5. Obesity. Increased weight from younger to older
ages is reported to be associated with statistically
significant increased risk of breast cancer for pre-
and post-menopausal women [49-53]. A study
reported that obese (BMI at least 30 kg/m2) post-
menopausal women have 31% excess risk compared
to those whose BMI is less than 25 kg/m2 [54].
Moreover, post-menopausal obesity seems to be an
important predictor of fatal breast cancer [55].
There are claims that there can be a protective
effect on the development of cancer by maintaining
normal BMI [56].6. Diet. Studies report that high consumption of fruit
and vegetables may offer significant protection
against breast cancer [57-60]. Meat, especially red
meat intake, is reported by some studies to be
associated with increased breast cancer risk [61-63],
though a few studies found no association [64,65]. A
review of 13 prospective studies claim that higher fat
intake does not confer excess risk of breast cancer
[66]. Polyunsaturated fatty acids, especially from fish
or shellfish, may offer protection, and saturated fat is
likely to increase the risk of breast cancer [67-69].
However, data about other dietary factors have been
inconsistent.
7. Physical activity. Increased total activity and
recreational physical activity especially after
menarche may decrease risk of breast cancer in
postmenopausal women [70,71]. Between 75 and
150 minutes per week of brisk walking appears to
decrease risk of breast cancer by 18% and strenuous
physical activity at age 35 (rather than at 18 or
50 years) seems to result in a 14% risk reduction
[71]. There seems to be a graded reduction in risk
with increasing years of exercise [72]. A study
reports that postmenopausal women with sedentary
occupations have 49% higher risk of breast cancer
than women in more physically demanding
occupations [73].
8. Smoking. There is evidence that smoking especially
during the period between menarche and first
childbirth may increase the risk of breast cancer
[74]. The increase in risk may be from 32% to 83%
in smokers [75,76].
9. Reproductive factors. Overall risk of breast cancer
in both pre- and post-menopausal women seems to
increase with increasing age of first childbirth or
first full term pregnancy, as well as with low parity
and a nulliparous state [37,77]. Women with an age
at first childbirth of 30 years or more are 5 to 7
times more likely to develop breast cancer compared
with those aged less than 20 years [78,79]. Each
additional birth may confer an average 10%
reduction in breast cancer risk [80].
10. Severe lifetime events. One study found that after
adjustment for age, menopause and other potential
confounders, severe life events increase the risk of
breast cancer by 11 times [81].
11.Chemicals and radiation. High exposure to
polycyclic aromatic hydrocarbons may increase
breast cancer risk by 50% [82]. Long term
(more than 15 years) exposure to organic solvents,
asbestos and vitreous fibres is likely to increase risk
by 1.5 to 2 times [83]. Medium and high levels of
occupational exposure to ionizing radiation,
combined exposure to chest x-rays and occupational
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(e.g. for skin problems) are reported to increase
breast cancer risk [84-86]. Exposure to sunlight may,
on the other hand, be protective for breast
cancer [87].
12.Healthy lifestyle index. A recent case control study
demonstrated that healthy lifestyle significantly
reduces the odds of having breast cancer in both pre
and post-menopausal women. Healthy lifestyle index
was considered as the combined effect of moderate
and/or vigorous-intensity physical activity, low
consumption of fat, processed foods, refined cereals,
complex sugars, and the avoidance of tobacco
smoking and alcohol consumption [88].
Findings from literature review about effective
interventions in reducing the risk of breast cancer
Our final list of variables for inclusion into the audit-
based education programme is those where change may
reduce the risk of breast cancer; they include: weight
control, dietary change, physical activity and reduction
of alcohol intake. These are all variables readily extracted
from primary care computer systems.
1. Weight control. Reduction in body weight is
reported to reduce breast cancer risk, especially in
postmenopausal women [49,89].
2. Diet. The evidence for effectiveness of dietary
change in reducing breast cancer risk is relatively
limited. A randomised trial in women with early stage
breast cancer reported that a reduction in the amount
of dietary fat of 18–19 g per day was associated with a
decreased risk of breast cancer recurrence [90].
3. Physical activity. A minimum of 150 minutes and
up to 420 minutes per week of moderate to vigorous
intensity physical activity may decrease the risk of
breast cancer [91].Figure 1 Age-sex profile of the combined practice populations.4. Alcohol intake reduction. There is evidence that
decreasing (by one drink or less per day) or stopping
alcohol consumption altogether may reduce breast
cancer risk in post-menopausal women [49,89].
Practice profile and inter-practice variation
The practices were drawn from across London, they
were largely in mixed areas with a social class distribu-
tion approximating to or just below the national average;
two practices could be described as inner city, and one
practice was located in a more affluent area. The practice
population had a population younger than the national
average, with an excess of younger women (Figure 1); The
mean age recorded in the first round of data collection
was 33.74 years while that recorded in the second round
was 32.90 years (Additional file 1: Table S1). The practice
populations had grown from a combined list size of
27,148 to 31,794 between the first and second data
collections, though there was no statistical difference in
the age-sex profile (Figures 2 and 3). Most of this growth
occurred in practice 6 (out of the 6 practices taking part),
which accounted for two-thirds of this growth (3,049/
4,646 = 65.6%) (Additional file 1: Table S1). There was
variation in the recording of data between practices be-
fore and after the intervention across the whole popula-
tion (Chi-square p < 0.001, Table 1). No single practice
had the highest level of recording in all domains.
Pilot audit-based education intervention
The baseline data collection of lifestyle factors took place
as planned with the exception of the technical problems
reported above. The focus of the practices action plan was
on improving quality of data recording at new patient
medicals.
We extracted a dataset that would provide insight
into whether the elements of a family history of breast
cancer identified in the literature review were recorded.
Figure 2 Age-band distribution by practice.
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of breast or bowel cancer recorded. This increased to
1.8% in the after group, with this history being
recorded for 2.8% of new patients (Table 2). Across the
risk factors there was a large rise in the recording of
information about family history of cancer in newFigure 3 Age-bands at first and last data collections.patients; though overall FH recording was a little lower
in new patients (40.6% compared with 43.0%). Alcohol
consumption and smoking were consistently almost
universally recorded; approximately three-quarters got
lifestyle advice. New patients had both less contracep-
tive needs and pregnancies recorded; though had much
Table 1 Variation in recording of key audit variables between practices for the first and second data collections in
Adult Population (over 18 years)
% All family history Family history of cancer Alcohol consumption Smoking status Lifestyle advice Practice population (n)
First data collection
Practice 1 33.6 2.8 89.2 97 75.8 3627
Practice 2 36.7 4.9 84.8 97 74.7 6158
Practice 3 34.4 7.4 65.3 96.5 74.7 3315
Practice 4 11.6 1.3 80.1 98.6 58.8 1841
Practice 5 57.5 10.2 73.8 95.6 81.4 3462
Practice 6 53 2.1 95.8 98.7 75 3000
All 39.3 5.1 81.9 97.1 74.6 21403
Chi square p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001
Second data collection
Practice 1 37.8 6.2 96.2 98.8 75.2 4161
Practice 2 40.5 8.1 89 98.1 77.7 6596
Practice 3 33.5 6.8 73 97.5 79.8 3285
Practice 4 13.6 2.5 80.6 99.2 50.7 1824
Practice 5 51.2 5.1 76.3 97.5 73.7 3512
Practice 6 45.7 1.9 90.8 97.2 60.5 5314
All 39.8 5.4 86 97.9 71.3 24692
Chi square p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001
The proportions were different for all key variables.
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placement therapy recorded.
After the educational intervention, there was an in-
crease in the rate of recording in all categories of data
other than ‘Life-style advice/education’ (Table 3). How-
ever, the 95% confidence intervals for family history and
family history of cancer data recording were not statisti-
cally significant; the Odds Ratio (OR) was 1.02 (95% CI
0.98 to 1.06); and 1.08 (95% CI 0.99 to 1.17) respectively.
There was a statistically significant, 36% increase in the
recording of alcohol consumption; (95% CI 1.30 to 1.43);
and 42% increase for smoking; (1.42, 95% CI 1.27 to
1.60). There was a fall of 16% in the recording of lifestyle
advice given which was also significant; the OR was 0.84
(95% CI 0.81-0.88). The changes by practices are shown
in Figure 4.
Qualitative findings – feedback from the workshop
The practices we approached readily agreed to participate,
and saw value in improving their data, and participating
in the audit. Qualitative feedback at the workshop high-
lighted how both practitioners recorded and computerised
medical record systems were inconsistent in how family
history was recorded; and stated that when new patients
register is the best time to improve recording. Discussions
with practitioners, at the time of the baseline data work-
shop and presentation revealed inconsistent use of codes,
others using high level non-specific codes (e.g. familyhistory of cancer) rather than disease specific codes. In
addition, there was very little use of negative codes (e.g. no
family history of breast cancer.) The computerised records
factors included reporting differences in where in the
system family history was recorded, inconsistency in
the information requested (for example some systems
asked which family member), and inconsistencies in the
coding system (for example there are codes for a nega-
tive family history of breast cancer, whereas there are
for no family history of bowel and ovarian cancer;
122 f. and 122G. respectively)). There are also family
history codes in different parts of the coding hierarchy;
practitioners did not like the codes that displayed an
asterisk (i.e. The family history of neoplasm, 124. codes,
display as FH *. The specific code for “FH*-breast” is
1243. They reported these as potentially paternalistic; it
felt to practitioners wrong that explicit records of a
family history of cancer were data that could not be
displayed as such on the computer screen and hence be
readily shared with the patient.
Discussion
Principal findings
Whilst overall the participants in the audit and feedback
intervention improved the quality of their data after the
audit, there was considerable variation reported between
practices and practitioners; and though some improved
their coding during the audit period, others did not. We
Table 2 Rates of recording of data relevant to the assessment of a family history of breast cancer, in adult females
(over 18 years)
% Practice
population
(N)
All family
history
FH of
neoplasm
FH of breast/
bowel cancer
Alcohol
intake
Smoking
status
Lifestyle
advice
Oral
contraception
Oestrogens/
HRT
Pregnancy
ever
Baseline
Practice
1
2105 36.4 3.8 0.9 92.4 98.8 78.9 14.9 5.9 19.5
Practice
2
3193 40.1 6.8 1.8 89.1 98.8 77.6 8.6 3.7 20
Practice
3
1646 37.7 8.6 2.3 72.2 98.1 73.9 9.2 13.7 22.4
Practice
4
908 14.5 1.5 0.7 87.3 99.8 64.3 5.9 14.1 21.5
Practice
5
1687 60.8 13.3 0.7 75.9 96.7 84.8 10.3 9.4 33.1
Practice
6
1658 56.9 2.4 1.1 98.3 99.5 77.6 6.1 2.2 15.8
All 11197 42.6 6.4 1.3 86.5 98.6 77.3 9.5 7.1 21.7
Post Audit
Practice
1
2481 41.8 7.7 2.5 97.9 99.6 76.1 20.8 10 15.9
Practice
2
3403 45.3 11 2.7 92 99.4 79.1 13.4 5.3 20
Practice
3
1644 36.6 7.8 1.9 80.1 99 79 14.7 18.3 22.6
Practice
4
911 15.9 2.7 0.9 87.4 99.9 53.9 8 21.3 22.5
Practice
5
1684 54.9 6.9 0.7 78.1 98.8 75.9 13.8 13.8 31.4
Practice
6
2839 46.6 2.3 1 93.3 98.6 59.5 8.3 0 19.6
All 12962 43.0 6.9 1.8 89.8 99.2 72 13.5 8.9 21.1
New patients
Practice
1
744 47.7 15.6 4.7 98.9 98.9 80 16.5 1.7 7.9
Practice
2
877 50.7 21.2 3.6 92.8 99.2 91.1 9.5 2.3 11.5
Practice
3
173 28.3 6.9 0.6 93.6 97.7 20.8 4.6 2.3 19.7
Practice
4
86 29.1 12.8 1.2 72.1 100 36 3.5 8.1 19.8
Practice
5
209 11.5 0.5 0 86.6 94.7 42.6 3.3 3.8 16.7
Practice
6
583 32.1 3.6 1 91.9 97.4 46.3 6.5 0 11.1
All 2672 40.6 13.0 2.8 93.2 98.3 68.1 9.8 19 11.6
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used to represent the same clinical problem, some prac-
titioners coded in a highly specific way while others were
much less specific using high level codes. The practi-
tioners who participated in our audit placed their em-
phasis on improving the quality of recording after doing
new patient medical examinations; this may lead to theanticipated rate of improvement in data quality to the
rate of turnover or growth of the practices when new
patients are registered.
Implications of the findings
Although general practice is encouraged to record family
history there are no national standards that need to be
Table 3 Odds ratios (OR) and 95% Confidence Intervals (CI) for a change in data recording between the first (baseline)
and second data collections
All family history FH of neoplasm Alcohol consumption Smoking status Lifestyle advice
Practice 1 1.20 2.33 3.03 2.43 0.97
OR (95% CI) (1.09 to 1.32)* (1.84 to 2.94)* (2.51 to 3.61)* (1.74 to 3.39)* (0.87 to 1.07)
Practice 3 1.18 1.72 1.45 1.57 1.18
OR (95% CI) (1.09 to 1.26)* (1.49 to 1.99)* (1.31 to 1.61)* (1.25 to 1.98)* (1.09 to 1.28)*
Practice 5 0.96 0.92 1.44 1.42 1.34
OR (95% CI) (0.87 to 1.07) (0.76 to 1.11) (1.29 to 1.60)* (1.07 to 1.90)* (1.20 to 1.51)*
Practice 2 1.20 1.96 1.03 1.66 0.72
OR (95% CI) (0.99 to 1.46) (1.19 to 3.32)* (0.88 to 1.21) (0.87 to 3.16) (0.63 to 0.82)
Practice 4 0.78 0.47 1.14 1.78 0.64
OR (95% CI) (0.71 to 0.85) (0.39 to 0.57) (1.02 to 1.27)* (1.36 to 2.32)* (0.57 to 0.72)
Practice 6 0.75 0.89 0.43 0.47 0.22
OR (95% CI) (0.68 to 0.82) (0.65 to 1.2294) (0.35 to 0.53) (0.33 to 0.67) (0.20 to 0.24)
All 1.02 1.08 1.36 1.42 0.84
OR (95%CI) (0.98 to 1.06) (0.99 to 1.17) (1.30 to 1.43)* (1.27 to 1.60)* (0.81 to 0.88)
An OR >1 suggests that data recording is more likely after the second data collection.
*statistically significant change.
Practice
Od
ds
 R
at
io
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
Alcohol consumption
 1  2  3  4  5  6
All family history
 1  2  3  4  5  6
FH of Neoplasm
 1  2  3  4  5  6
Lifestyle advice
 1  2  3  4  5  6
Smoking status
 1  2  3  4  5  6
Figure 4 Odds ratios (OR) and 95% Confidence Intervals (CI) for a change in data recording between the first (baseline) and second
data collections. An OR >1 suggests that data recording is more likely after the second data collection. Only practice 3 had the OR of recording
all data domains increased after the intervention than before.
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http://www.biomedcentral.com/1471-2296/14/105adhered to; this should be corrected. Pilot practices
appeared willing to engage in this initiative and we hope
that a broader group of practices would want to engage
in this type of quality improvement. Although we did
achieve some progress, the rate of progress was slow.
Moreover, despite our assumption that improved data
recording might be found in new patients, we would
hope that existing patients might also benefit from this
intervention. Raising awareness about good quality re-
cording would steadily improve recording and data
quality over time. We should consider building on this,
maybe creating a preferred list of codes that could
appear in a data entry form, or template, to facilitate the
consistent collection of data which has been collected in
this audit. A recommended code list could facilitate data
entry and the audit of quality; and ultimately the quality
of care.
Limitations of the method
Integrated risk assessment tools for cancer are not em-
bedded within primary care computer records. We did
not explore whether integrated tools would be a greater
stimulus to data recording and risk assessment. Such
systems would raise awareness around familial breast
cancer and then allow direct integration of family history
into electronic GP records.
The data we looked at were those related to reducing
cancer risk. Recording of these data per se does not
mean that a risk assessment has been carried out. We
made the same assumptions as when we have critically
appraised diabetes [22,23]; namely that data recording
approximates to the clinician’s engagement with the care
process whilst recognising that computer data can under
or over represent the actual care provided to an individ-
ual patient.
There were gaps in the data collection, particularly
BMI data; however this aspect of the project is probably
the easiest to put right.
We did not take into account women’s views of how
they perceive risk, the current services, or where they
see gaps in provision [92-94].
It is recognised that good quality recording of family
history is a neglected theme in providing care, and more
could be done in primary care [95,96]. Other studies
have also found recording of family history of breast
cancer to be limited in terms of recording [97].
The theory of diffusion of innovation may provide
insights into how change in data recording may be
adopted [98]. This theory describes the very slow pro-
cess whereby innovators take on a new process, followed
by early adopters, and followed in sequence by other
groups. However diffusion can be a slow process, taking
many years – an intervention like audit based education
might accelerate uptake of guidance. Other initiativeshave required the setting of a recommended coding list
to encourage consistency of coding [99]. Involvement of
the appropriate primary care society and support from
cancer charities, professional associations and academies
may also facilitate the uptake of good and accurate data
recording. Since initial risk assessment of a new patient
is a crucial component which takes place at new patient
medicals, then practice nurses will also need appropriate
education [100].
Inconsistencies in family history recording were likely
to be related to data recording rather than data extrac-
tion. Other than our queries having a code error for
BMI, the data collectors did not report any problems
with data extraction, we have a set format for reporting
these [92]. In the qualitative results section we explained
how personal practitioner preference for using either
generic or specific codes, and the nature of the coding
system was responsible for variation in the prevalence
and granularity of the coding used. In addition, variation
in picking-lists (the lists practitioners select codes from)
and different ways that computerised medical record
system vendors create these lists tends to foster and
perpetuate differences in coding between practices [101].
The creation of limited lists of codes for pay-for-per-
formance that has driven standardisation of coding
[102]. We have demonstrated some success with a simi-
lar approach, a recommended limited list of codes, for
the recording child safeguarding issues in primary care;
where flagging issues can help with stratifying risks in
later consultations [103].
Call for further research
A consensus building exercise is needed to offer pre-
ferred coding strategies. Risk stratifying software should
be piloted and compared with ABE and usual practice,
as a tool for conducting risk assessments. Looking at
rates of appropriate referral for breast assessment would
be one measure. Measuring the need for genetic coun-
selling or onward referral to genetics centres could serve
as another outcome measure. The opportunity now ex-
ists for building on what has been learned from previous
trials, which took place prior to the widespread use of
computers to support chronic disease management
[104,105]. Strategies such as providing online risk assess-
ment tools, directly to patients, could be considered,
however a recent trial has indicated that such online
tools may have limited impact [106].
Conclusions
We implemented audit-based education (ABE) in six
practices; and it has provided insight into the level of
data recording, and that improved assessment of family
history and other risk factors is most easily improved at
the time of new patient appointments. However, more
Rafi et al. BMC Family Practice 2013, 14:105 Page 11 of 14
http://www.biomedcentral.com/1471-2296/14/105needs to be done to improve assessment across practice
populations.
There was no significant change in the recording of
family history of disease or cancer after the audit, though
the recording of risk factors improved.
The study provided insight into variation and issues with
current data recording, the willingness of practitioners to
collaborate and rate of change achieved by audit and feed-
back. Whilst recording of risk factors improved with
audit-based education further interventions are needed to
raise data quality and care to standards where people with
a small increased risk are adequately flagged in primary
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